Latest News and Reviews

Cancer-causing genes removed from engineered stem cells may help in Parkinson’s disease research

At the Whitehead Institute for Biomedical Research in Massachusetts, the revelation came through when scientist developed new ways to singled out potential cancer creating genes during the reprogramming of skin cells from Parkinson’s disease into an embryonic-stem-cell-like state. The resulting induced pluripotent stem (iPS) cells may have been used by the researchers as the nascent and new born cells to make a breakthrough cure for major illness such as Parkinson’s disease.

The researchers have written in their journals that they have changed the IPS cells into those causing Parkinson’s. The problem of having alien cells as is in the case of organ transplants is no more as the IPS could be produced  from a patient’s own skin cells. These IPS cells may carve out efficient cells to replace the torn and disabled ones through big ailments in coming time. They are also acting as guinea pigs to provide the researcher with ready testing stuff.

Scientist knew that genes can reprogram to translate one cell into a prototype resembling embryonic stem cell; a situation from where there can be generation of many kinds. But these genes may be carrying cancer units though and may harmfully react with the multitude of other cells to cause out of hand problems.

The research team employed viruses to intervene a trio of genes into the skin cells Parkinson’s affected people and then removed them after the finding had been attested. The outcome was the cells that resembled the embryonic cells a lot, without extra genes. The IPS cells were then used to create dopamine building neural cells that make the brain slow and desiccate in the body suffering from Parkinson’s causing the hard symptoms of severe shaking, lethargy and imbalance.

The finding is a novelty where the IPS cells have not lost their embryonic stem-cell-like properties while the remade genes have been cast out.